Загрузка...
SUN-700 Fournier’s Gangrene and Diabetic Ketoacidosis Caused by Canagliflozin
Introduction Sodium glucose co-transporter 2 (SGLT2) inhibitors have become an appealing treatment for diabetes due to their favorable cardiac and renal outcomes. However, reports continue to emerge describing potentially life-threatening adverse events such as Fournier’s gangrene (FG) and diabetic...
Сохранить в:
| Опубликовано в: : | J Endocr Soc |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7208740/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.984 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|